Rubella Vaccine
Inventor(s)
Tech ID
PS-111
Key Words
rubella, Vaccine
Applications and Advantages
The RA 27/3 seed stock may be used for development of vaccines that may be available at a lower cost than those vaccines produced by the major pharmaceutical companies.
Intellectual Property Status
The Wistar Institute can provide the proprietary biological material used to make the vaccines.
Licensing Opportunity
The RA27/3 strain of rubella virus is available for licensing outside of the United States.
